Hospira joins Spanish generics association
This article was originally published in Scrip
The US-based company,Hospira, is now a member ofAESEG, the Spanish generic medicines industry association. The association now represents 28 companies, including those which market, develop or produce generic medicines and those which develop the raw materials.
You may also be interested in...
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.